Idea or Concept – Page 22

Applied Therapeutics Stock Surges After FDA Cancels Advisory Meeting for Govorestat

12 months ago talkbio0Tagged Advisory Meeting, Galactosemias, Govorestat, surge, United States Food and Drug Administration

Applied Therapeutics, FDA, Govorestat, Advisory Meeting, Classic Galactosemia, Stock Surge

HPV-Based Cervical Cancer Screening: Insights into Sample Preference and Cost-Effectiveness

12 months ago talkbio0Tagged Cost Effectiveness, Human papilloma virus screening, Malignant tumor of cervix, preference, Screening guidelines, Specimen

HPV testing, Cervical cancer screening, Sample preference, Cost-effectiveness, Screening guidelines

Cigna’s Express Scripts Files Lawsuit Against FTC Over Allegedly Biased PBM Report

12 months ago talkbio0Tagged Biases, Erroneous, Express, Health care facility, lawsuit, Pharmacy Benefit Manager, Prices, Report (document), United States Federal Trade Commission

Express Scripts, FTC, PBM Report, Lawsuit, Biased, Erroneous, Drug Prices, Healthcare

Boehringer Ingelheim Prepares NDA Filing for Pulmonary Fibrosis Drug After Positive Phase 3 Results

12 months ago talkbio0Tagged boehringer ingelheim, Idiopathic Pulmonary Fibrosis, NDA, nerandomilast, Phase 3, Pulmonary Fibrosis

Boehringer Ingelheim, pulmonary fibrosis, NDA filing, Phase 3 data, nerandomilast, idiopathic pulmonary fibrosis (IPF)

Roche’s Obesity Pill Candidate Faces Safety Concerns Amid Promising Efficacy Results

1 year ago talkbio0Tagged aspects of adverse effects, concerns, Contraceptives, Oral, CT-996, Effectiveness, Gastrointestinal Issues, Nausea, Obesity, Roche (company), Safety, Vomiting

Roche, Obesity Pill, Safety Concerns, Efficacy Data, CT-996, Side Effects, Nausea, Vomiting, Gastrointestinal Issues

BridgeBio Cuts Gene Therapy Budget by Over $50 Million Following Disappointing Early-Phase Data

1 year ago talkbio0Tagged BBP-631, BridgeBio, Budgets, Congenital adrenal hyperplasia, early-phase, gene therapy

BridgeBio, gene therapy, budget cut, early-phase data, CAH treatment, BBP-631, congenital adrenal hyperplasia

Highlander Health: Revolutionizing Clinical Research with Integrated Solutions

1 year ago talkbio0Tagged Abernethy, Clinical Research, enablement, Evidence, Generations, Health care facility, Highlander Health, Hirsch, Technology, United States Food and Drug Administration

Highlander Health, clinical research, personalized healthcare, evidence generation, technology enablement, Amy Abernethy, Brad Hirsch, Verily, FDA.

BIOSECURE Act Clears House Hurdle, Heads to Senate for Vote on Restricting Chinese Biotech Ties

1 year ago talkbio0Tagged BIOSECURE, Biotech Companies, Biotechnology, Chinese Language, Drug Industry, drug supply chain, innovation, National Security, Risk, Senate, United States, US House of Representatives, Voting

BIOSECURE Act, House of Representatives, Senate Vote, Chinese Biotech Companies, National Security Risks, U.S. Pharmaceutical Industry, Biotechnology Innovation, Drug Supply Chain

Abbott Launches Lingo, First Over-the-Counter Continuous Glucose Monitor for Health and Wellness in the US

1 year ago talkbio0Tagged abbott, continuous glucose, Continuous Glucose Monitoring System, Health, Lingo, Preventive monitoring

Abbott, Lingo, Over-the-Counter CGM, Health and Wellness, Continuous Glucose Monitoring

Johnson & Johnson Boosts Talc Settlement by $1.1 Billion Amid Ongoing Negotiations

1 year ago talkbio0Tagged Bankruptcy, Increase, Infantile Neuroaxonal Dystrophy, Johnson and Johnson, Talc Settlement

Johnson & Johnson, Talc Settlement, $1.1 Billion Increase, Cancer Lawsuits, Bankruptcy Plan